From: Case report: Infective endocarditis caused by Brevundimonas vesicularis
Reference | Age (y)/sex | Underlying disease | Clinical presentation | Treatment/duration | Outcome |
---|---|---|---|---|---|
(8)/NI | 54/F | SLE, autoimmune hepatitis, steroid therapy | Necrotizing cellulitis | Tobramycin + ceftazidime/30d | Survival |
(9)/NI | 42/F | Mitral valve stenosis s/p mitral valve replacement | Septicaemia | Piperacillin - tazobactam/14d | Survival |
(10)/CA | 5/M | Sickle cell anemia | Pneumonia | Ceftriaxone + gentamicin/10d | Survival |
(11)/NI | 59–67/both | Hemodialysis | Septicaemia | Cefotaxime + tobramycin/unknown | Survival |
(12)/CA | 60/M | Trauma | Botryomycosis | Cefuroxime- axetil/4 months | Survival |
(13)/CA | 38/M | No | Acute tonsillitis | amoxicillin- clavulanate/3d | Survival |
(14)/CA | 1.25/F | No | Septic arthritis | cefuroxime/12d + oral cephalexin/14d | Survival |
(15)/CA | 55/M | Continuous ambulatory peritoneal dialysis | peritonitis | ceftazidime/3d, ceftazidime + vancomycin/4d, ciprofloxacin + aztreonam/14d | Survival |
current case/CA | 40/M | No | Subacute endocarditis | cefazolin + gentamicin/3 d, Ampicillin/sulbactam + gentamicin/5 d, Ceftriaxone + gentamicin/7 d, ciprofloxacin/30 d | Survival |